# Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma

> **NCT06490003** · — · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 150 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma
- Chemotherapy Effect
- DNA Methylation

## Interventions

- **DRUG:** Fluoro Uracil

## Key facts

- **NCT ID:** NCT06490003
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2004-06-01
- **Primary completion:** 2026-06-18
- **Final completion:** 2026-06-18
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06490003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06490003, "Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06490003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*